Dr. DeVita Receives 1995 Durham City Of Medicine Award

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 12
Volume 4
Issue 12

NEW HAVEN, Conn--Vincent T. DeVita, Jr., MD, director of the Yale Cancer Center, has been honored with the 1995 Durham City of Medicine Award.

NEW HAVEN, Conn--Vincent T. DeVita, Jr., MD, director of the YaleCancer Center, has been honored with the 1995 Durham City of MedicineAward.

The award program was established in 1988 by the City of Durham,NC, to recognize internationally renown medical scientists andorganizations whose contributions to medicine have profoundlyimproved the health and welfare of millions of people. Recipientsinclude five Nobel Laureates in Medicine.

Dr. DeVita, who served as director of the National Cancer Institutefor 8 years, has been a leader in the war against cancer for thepast 30 years. His ground-breaking research in multidrug chemotherapyregimens to treat cancer has provided a cure for Hodgkin's diseaseand other lymphomas.

Recent Videos
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content